http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013130524-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60cabc4ce80d392076a1eaf2a970a548 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f04310d74fb7cacbf141decd2ace3f2e |
| publicationDate | 2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013130524-A |
| titleOfInvention | Diagnosis of end-stage renal failure |
| abstract | The present invention provides a method for diagnosing end-stage renal failure and transition from chronic renal failure to end-stage renal failure using a reliable index that more reflects the functional state of the kidney. Measuring the amount of aquaporin 1 and aquaporin 2 in the urine of a subject, and the amount of aquaporin 1 and aquaporin 2 in the urine of the subject, the amount of aquaporin 1 and aquaporin 2 in the urine of a control When the amount of aquaporin 1 and aquaporin 2 in the subject's urine is reduced to 10% or less compared to the amount of aquaporin 1 and aquaporin 2 in the control urine A method of determining that the patient has end-stage renal failure or is in the transitional stage to end-stage renal failure. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109266616-A |
| priorityDate | 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.